{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:49:03Z","timestamp":1791740943895,"version":"4.3.4"},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T00:00:00Z","timestamp":1543363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To report the clinical experience with a second\u2010generation of temporary implantable nitinol device (iTIND; Medi\u2010Tate Ltd, Or\u2010Akiva, Israel) for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) after 1 year of follow\u2010up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      In all, 81 patients with LUTS, International Prostate Symptom Score (IPSS) \u226510, maximum urinary flow rate (Q\n                      <jats:sub>max<\/jats:sub>\n                      ) \u226412 mL\/s, and prostate volume &lt;75 mL, were enrolled in this prospective Research Ethics Committee\u2010approved multicentre study. The main exclusion criteria were: haemostatic disorders, post\u2010void residual urine volume (PVR) &gt;250 mL, obstructive median lobe, and previous prostate surgery. The iTIND was implanted within the bladder neck and the prostatic urethra under light sedation, using a rigid cystoscope. The device was removed 5\u20137 days later in an outpatient setting. Demographics, perioperative results, complications (according to the Clavien\u2013Dindo system), functional results and quality of life (QoL) were evaluated. Follow\u2010up assessments were conducted at 1, 3, 6 and 12 months postoperatively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean (\n                      <jats:sc>sd<\/jats:sc>\n                      ) patient age was 65 (8.9) years, prostate volume was 40.5 (12.25) mL, Q\n                      <jats:sub>max<\/jats:sub>\n                      was 7.3 (2.6) mL\/s, IPSS was 22.5 (5.6), and the median (interquartile range) IPSS QoL score was 4 (2\u20135). All the implantations were successful, with no intraoperative complications recorded; all patients were discharged on the same day of surgery. The devices were retrieved at a mean (SD) of 5.9 (1.1) days after implantation, typically under topical anaesthesia. No Clavien\u2013Dindo Grade &gt;II complications were recorded. The mean (SD) Q\n                      <jats:sub>max<\/jats:sub>\n                      at the 1 month follow\u2010up visit was 11.2 (5.7) mL\/s and continued to improve thereafter, reaching 14.7 (8.1) mL\/s at the 12\u2010month follow\u2010up visit (+100%). The mean (SD) IPSS urinary symptom scores were 11.7 (8.0) after 1 month and further improved to 8.8 (6.4) at the 12\u2010month follow\u2010up (\u221260%). In parallel, the mean (SD) IPSS QoL score drop reached 1.6 (1.3) by the end of the study. During the 12\u2010month period, two patients (2.4%) required medical therapy for BPH, two patients (2.4%) required transurethral resection of the prostate, whilst 10 patients were lost to follow\u2010up (12.3%). As compared to baseline, none of the 61 sexually active patients who completed the 12\u2010month follow\u2010up period reported sexual or ejaculatory dysfunction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>iTIND implantation is feasible, safe and effective in providing relief of BPH\u2010related symptoms, at least until 12 months postoperatively. Sexual and ejaculatory functions are fully preserved. Further studies with a longer follow\u2010up period are needed to assess the durability of these results and to clearly define the indications for iTIND implantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.14608","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T05:22:51Z","timestamp":1541049771000},"page":"1061-1069","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Second\u2010generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow\u2010up"],"prefix":"10.1111","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8567-6795","authenticated-orcid":false,"given":"Francesco","family":"Porpiglia","sequence":"first","affiliation":[{"name":"Division of Urology Department of Oncology\u2010 School of Medicine San Luigi Hospital University of Turin Orbassano (Turin) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Fiori","sequence":"additional","affiliation":[{"name":"Division of Urology Department of Oncology\u2010 School of Medicine San Luigi Hospital University of Turin Orbassano (Turin) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Amparore","sequence":"additional","affiliation":[{"name":"Division of Urology Department of Oncology\u2010 School of Medicine San Luigi Hospital University of Turin Orbassano (Turin) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Kadner","sequence":"additional","affiliation":[{"name":"Division of Urology Spital Thurgau Frauenfeld Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Manit","sequence":"additional","affiliation":[{"name":"Division of Urology University College London Hospitals London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Valerio","sequence":"additional","affiliation":[{"name":"Division of Urology Centre Hospitalier Universitaire Vaudois Lausanne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1242-3644","authenticated-orcid":false,"given":"Lumen","family":"Nicolaas","sequence":"additional","affiliation":[{"name":"Division of Urology Gent University Hospital Ghent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9893-1326","authenticated-orcid":false,"given":"Brian S. H.","family":"Ho","sequence":"additional","affiliation":[{"name":"Division of Urology Queen Mary Hospital Hong Kong City Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Alonso","sequence":"additional","affiliation":[{"name":"Division of Urology La Paz University Hospital Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Schulman","sequence":"additional","affiliation":[{"name":"Division of Urology CHIREC Cancer Institute (CCI) Urology Brussels Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Barber","sequence":"additional","affiliation":[{"name":"Division of Urology Frimley Health London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11,28]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.03.004"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-015-1206-7"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.01.074"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-015-0090-x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-005-3232-x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.06.001"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.12.038"},{"key":"e_1_2_8_9_1","first-page":"446","article-title":"From \u201cgold standard\u201d resection to reproducible \u201cfuture standard\u201d endoscopic enucleation of the prostate: what we know about anatomical enucleation","volume":"69","author":"Naspro R","year":"2017","journal-title":"Minerva Urol Nefrol"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1999.00908.x"},{"key":"e_1_2_8_11_1","first-page":"109","article-title":"Green light vaporization of the prostate: is it an adult technique?","volume":"69","author":"Brassetti A","year":"2017","journal-title":"Minerva Urol Nefrol"},{"key":"e_1_2_8_12_1","first-page":"285","article-title":"Comparison of GreenLight laser and transurethral resection of the prostate baseline characteristics and outcomes: lessons learned from the Clinical Research Office f the Endourological Society GreenLight Laser Study","volume":"69","author":"Muir G","year":"2017","journal-title":"Minerva Urol Nefrol"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13897"},{"key":"e_1_2_8_14_1","first-page":"119","article-title":"New treatment strategies for benign prostatic hyperplasia in the frail elderly population: a systematic review","volume":"69","author":"Albisinni S","year":"2017","journal-title":"Minerva Urol Nefrol"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000386"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10342.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2016.05.003"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.02.3088"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12982"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14141"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-018-0793-0"},{"key":"e_1_2_8_22_1","first-page":"242","article-title":"The influence of the medical treatment of LUTS on benign prostatic hyperplasia surgery: do we operate too late?","volume":"69","author":"Presicce F","year":"2017","journal-title":"Minerva Urol Nefrol"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.01.088"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-6-14"},{"key":"e_1_2_8_25_1","first-page":"CD004135","article-title":"Microwave thermotherapy for benign prostatic hyperplasia","author":"Hoffman RM","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/end.2010.0201"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14404"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11884-017-0424-5"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/iju.12866"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.14608","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.14608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:31:03Z","timestamp":1761737463000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.14608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,28]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1111\/bju.14608"],"URL":"https:\/\/doi.org\/10.1111\/bju.14608","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,28]]},"assertion":[{"value":"2018-11-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}